Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study

被引:9
作者
Chidambaram, Swathikan [1 ]
Owen, Richard [2 ,3 ]
Sgromo, Bruno [2 ]
Chmura, Magdalena [2 ]
Kisiel, Aaron [4 ]
Evans, Richard [4 ]
Griffiths, Ewen A. [4 ]
Castoro, Carlo [5 ]
Gronnier, Caroline [6 ]
Maoawyes, Mometo Ali [7 ]
Gutschow, Christian A. [7 ]
Piessen, Guillaume [8 ]
Degisors, Sebastien [8 ]
Alvieri, Rita [9 ]
Feldman, Hope [10 ]
Capovilla, Giovanni [11 ]
Grimminger, Peter P. [11 ]
Han, Shiwei [12 ,13 ]
Low, Donald E. [12 ,13 ]
Moore, Jonathan [14 ]
Gossage, James [14 ]
Voeten, Dan [15 ]
Gisbertz, Suzanne S. [15 ]
Ruurda, Jelle [16 ]
van Hillegersberg, Richard [16 ]
D'Journo, Xavier B. [17 ]
Chmelo, Jakub [18 ]
Phillips, Alexander W. [18 ]
Rosati, Riccardo [19 ]
Hanna, George B. [1 ]
Maynard, Nick [2 ]
Hofstetter, Wayne [10 ]
Ferri, Lorenzo [20 ]
Berge Henegouwen, Mark I. [15 ]
Markar, Sheraz R. [2 ,21 ]
机构
[1] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit, London, England
[2] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Surg, Oxford, England
[3] Univ Oxford, Ludwig Inst Canc Res, Oxford, England
[4] Birmingham Univ Hosp NHS Fdn Trust, Queen Elizabeth Hosp, Dept Surg, Birmingham, England
[5] Humanitas Res Hosp, Gen Gastr & Esophagus Surg Unit, Rozzano, Italy
[6] CHU Bordeaux, Ctr Magellan, Digest Surg Dept, Esophageal & Endocrine Surg Unit, Bordeaux, France
[7] Univ Hosp Zurich, Comprehens Canc Ctr, Stomach & Oesophageal Tumor Ctr, Zurich, Switzerland
[8] Univ Hosp Claude Huriez, Dept Digest & Gen Surg, Cedex, Lille, France
[9] IOV IRCCS, Veneto Inst Oncol, Oncol Surg Unit, Padua, Italy
[10] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[11] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Surg, Mainz, Germany
[12] Virginia Mason Hosp, Dept Thorac Surg & Thorac Oncol, Seattle, WA USA
[13] Seattle Med Ctr, Seattle, WA USA
[14] Guys & St Thomas Hosp NHS Fdn Trust, Dept Surg, London, England
[15] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[16] Univ Med Ctr, Dept Upper Gastrointestinal Surg, Utrecht, Netherlands
[17] North Hosp, Dept Thorac Surg Dis Esophagus & Lung Transplantat, Chemin Bourrely, Marseille, France
[18] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Esophagogastr Unit, Newcastle Upon Tyne, England
[19] Osped San Raffaele, Dept GI Surg, Milan, Italy
[20] McGill Univ, Montreal Gen Hosp, Dept Surg & Oncol, Montreal, PQ, Canada
[21] Univ Oxford, Nuffield Dept Surg, Oxford, England
关键词
chemoradiotherapy; esophageal cancer; esophagectomy; salvage esophagectomy; PHASE-III TRIAL; RADIATION-THERAPY; SURGERY; CHEMORADIATION; RADIOTHERAPY; MORBIDITY; MORTALITY; SURVIVAL; OUTCOMES;
D O I
10.1097/SLA.0000000000006028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of delayed surgical intervention following chemoradiotherapy (CRT) on survival from esophageal cancer.Background: CRT is a core component of multimodality treatment for locally advanced esophageal cancer. The timing of surgery following CRT may influence the probability of performing an oncological resection and the associated operative morbidity.Methods: This was an international, multicenter, cohort study, including patients from 17 centers who received CRT followed by surgery between 2010 and 2020. In the main analysis, patients were divided into 4 groups based upon the interval between CRT and surgery (0-50, 51-100, 101-200, and >200 days) to assess the impact upon 90-day mortality and 5-year overall survival. Multivariable logistic and Cox regression provided hazard ratios (HRs) with 95% CIs adjusted for relevant patient, oncological, and pathologic confounding factors.Results: A total of 2867 patients who underwent esophagectomy after CRT were included. After adjustment for relevant confounders, prolonged interval following CRT was associated with an increased 90-day mortality compared with 0 to 50 days (reference): 51 to 100 days (HR=1.54, 95% CI: 1.04-2.29), 101 to 200 days (HR=2.14, 95% CI: 1.37-3.35), and >200 days (HR=3.06, 95% CI: 1.64-5.69). Similarly, a poorer 5-year overall survival was also observed with prolonged interval following CRT compared with 0 to 50 days (reference): 101 to 200 days (HR=1.41, 95% CI: 1.17-1.70), and >200 days (HR=1.64, 95% CI: 1.24-2.17).Conclusions: Prolonged interval following CRT before esophagectomy is associated with increased 90-day mortality and poorer long-term survival. Further investigation is needed to understand the mechanism that underpins these adverse outcomes observed with a prolonged interval to surgery.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [31] Chemoradiotherapy for esophageal squamous cell cancer
    Sasaki, Yusuke
    Kato, Ken
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (09) : 805 - 810
  • [32] Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer Outcomes and patterns of failure
    Haefner, Matthias Felix
    Lang, Kristin
    Verma, Vivek
    Koerber, Stefan Alexander
    Uhlmann, Lorenz
    Debus, Juergen
    Sterzing, Florian
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (02) : 116 - 124
  • [33] OPTIMAL TIMING OF ENDOSCOPIC EVALUATION OF THE PRIMARY SITE OF ESOPHAGEAL CANCER AFTER CHEMORADIOTHERAPY OR RADIOTHERAPY: A RETROSPECTIVE ANALYSIS
    Zenda, Sadamoto
    Hironaka, Shuichi
    Taku, Keisei
    Sato, Hiroshi
    Hashimoto, Takayuki
    Hasuike, Noriaki
    Boku, Narikazu
    Tsubosa, Yasuhiro
    Ono, Hiroyuki
    Nishimura, Tetsuo
    DIGESTIVE ENDOSCOPY, 2009, 21 (04) : 245 - 251
  • [34] Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer
    Wongwaiyut, Kraipop
    Ruangsin, Sakchai
    Laohawiriyakamol, Supparerk
    Leelakiatpaiboon, Siriporn
    Sangthawan, Duangjai
    Sunpaweravong, Patrapim
    Sunpaweravong, Somkiat
    JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (03) : 947 - 951
  • [35] Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer
    Wang, Bing-Yen
    Hung, Wei-Heng
    Wu, Shiao-Chi
    Chen, Heng-Chung
    Huang, Chang-Lun
    Lin, Ching-Hsiung
    Chen, Hui-Shan
    ANNALS OF THORACIC SURGERY, 2019, 107 (04) : 1060 - 1067
  • [36] Surgical treatment of esophageal cancer. Evolution of management and prognosis over the last 3 decades
    Glatz, T.
    Marjanovic, G.
    Zirlik, K.
    Brunner, T.
    Hopt, U. T.
    Makowiec, F.
    Hoeppner, J.
    CHIRURG, 2015, 86 (07): : 662 - 669
  • [37] Retrospective analysis of patients with esophageal cancer treated with radiotherapy and/or chemoradiotherapy
    Kandaz, Mustafa
    Ertekin, Mustafa Vecdi
    Bilici, Mehmet
    TUMORI, 2012, 98 (04) : 445 - 450
  • [38] Advances in the Surgical Management of Esophageal Cancer
    Sihag, Smita
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (03) : 559 - 568
  • [39] Overall survival after definitive chemoradiotherapy for patients with esophageal cancer: a retrospective cohort study
    van der Zijden, Charlene J.
    Bouwman, Anna
    Mostert, Bianca
    Nuyttens, Joost J. M. E.
    van der Sluis, Pieter C.
    Spaander, Manon C. W.
    Mens, Jan Willem M.
    Homs, Marjolein Y., V
    van Doorn, Leni
    Wijnhoven, Bas P. L.
    Lagarde, Sjoerd M.
    DISEASES OF THE ESOPHAGUS, 2024, 37 (10)
  • [40] Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Jeong, Yuri
    Kim, Jong Hoon
    Kim, Sung-Bae
    Yoon, Dok Hyun
    Park, Seung Il
    Kim, Yong Hee
    Kim, Hyeong Ryul
    Jung, Hwoon Yong
    Lee, Gin Hyug
    Ryu, Jin-Sook
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (05) : 472 - 477